Acquired Immunodeficiency Syndrome: all 3,037 studies
Page 24 of 31. Open to participants first (307), then studies with results posted, then the rest; newest registration first within each.
- Validation of System for Monitoring the Effectiveness of Antiretroviral Therapy in HIV-Infected Patients in AfricaCompletedNCT00341393
- A Prospective, Observational Study of HIV-Infected Pregnant Women and Their Infants at Clinical Sites in Latin American and Caribbean CountriesCompletedNCT00341302
- Specimens From Normal ControlsCompletedNCT00341211
- The Effects of Genetic Differences Among AIDS Patients on Cytomegalovirus RetinitisCompletedNCT00341172
- Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)TerminatedNCT00340548
- HLA-B35 Alleles and AIDSWithdrawnNCT00340223
- NISDI Pediatric Latin American Countries Epidemiologic Study (PLACES): A Prospective Observational Study of HIV-Infected Children at Clinical Sites in Latin American CountriesCompletedNCT00339612
- Socioenvironmental Determinants of Psychological Functioning, Mental Health and AIDS in MaliCompletedNCT00339391
- Antidepressant Medication Plus Directly Observed Therapy for Improving Adherence to Antiretroviral TherapyCompletedNCT00338767Phase 2
- A Randomized Trial of IUD Versus Hormonal Contraception in HIV-infected Women in ZambiaCompletedNCT00336245Phase 3
- Leukapheresis to Obtain Lymphocytes for Studies on Antiretroviral Naive HIV-infected PatientsCompletedNCT00333892
- Study to Assess Safety and Quality of Life of Patients Using Biojector Versus Needles for Fuzeon AdministrationCompletedNCT00333736Phase 2
- Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-AlcamidCompletedNCT00333684Phase 2
- Thai Prophylactic HIV Vaccine Phase I StudyTerminatedNCT00333424Phase 1/2
- Sildenafil to Treat HIV-Associated Pulmonary HypertensionTerminatedNCT00327080Phase 1
- Multidisciplinary Inpatient Palliative Care InterventionCompletedNCT00325611Not applicable
- HIV Prevention Intervention for CouplesCompletedNCT00325585Phase 2
- Comparison of Abacavir Following Once-Daily And Twice-Daily Administration In HIV Infected SubjectsCompletedNCT00320307Phase 1
- An Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT� (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients (CHAMPS II)CompletedNCT00317902Phase 4
- Buprenorphine and Integrated HIV CareCompletedNCT00317460Phase 4
- Acupuncture/Moxibustion for Peripheral Neuropathy in HIVCompletedNCT00317291Phase 2
- A Mindfulness Based Approach to HIV Treatment Side EffectsCompletedNCT00312936Phase 1/2
- Study Comparing Reducing the Dose of Stavudine Versus Switching to Tenofovir in HIV-Infected Patients Receiving Antiretroviral TherapyCompletedNCT00312832Not applicable
- Examining the Link Between Heart Disease and HIV Infection in WomenCompletedNCT00312468
- Nutrition, Diabetes and Pulmonary TB/HIVCompletedNCT00311298Phase 3
- The Prevalence of Vitamin D Deficiency and Effects of Vitamin D Supplementation in HIV-1 Infected PatientsStatus unknownNCT00306410Phase 2
- Intensification With Enfuvirtide in Naive HIV-infected Patients (ANRS130)CompletedNCT00302822Phase 3
- DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP)TerminatedNCT00302341Phase 3
- Antiretroviral Treatment Simplified Follow-up Management Assessment (ANRS 12110 STRATALL)CompletedNCT00301561Phase 3
- Randomized, Double-Blind Study Comparing Dexelvucitabine (DFC) to Lamivudine (3TC) in Subjects With Resistance to NRTIs, PIs, and NNRTIsTerminatedNCT00300573Phase 2
- Evaluation of an HIV Outreach ProgramCompletedNCT00300183
- Engagement in HIV Primary Care ServicesCompletedNCT00300170
- SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV PatientsStatus unknownNCT00299897Phase 2
- A Dose Response and Safety Study of Procaine HCl in HIV-Infected PatientsCompletedNCT00299338Phase 1/2
- Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART.CompletedNCT00298350Phase 2
- Omacor and Cardiovascular Risk Factors in HIV Patients on HAART TreatmentCompletedNCT00296153Phase 4
- BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's SarcomaTerminatedNCT00287495Phase 1
- Pharmacokinetic Study of Interaction Between Nevirapine and Methadone in HIV-1 Infected, Opioid-dependent AdultsCompletedNCT00273988Phase 4
- Life Skills Intervention for Adolescents Perinatally Infected With HIVCompletedNCT00272519Not applicable
- Longitudinal Study of HAART, Social Networks, & AdherenceCompletedNCT00272220Not applicable
- C2P (With Venues): Connect to Protect® Partnerships For Youth Prevention InterventionsCompletedNCT00271908
- Social and Economic Outcomes of HIV/AIDS Care and Treatment in HIV Infected South African AdultsCompletedNCT00270764
- Impact of Anti-HIV Treatment on Labor Productivity and Costs in South AfricaWithdrawnNCT00270725
- Safety and Immune Response to a Prime-Boost Vaccination Schedule in HIV-infected PatientsCompletedNCT00270465Phase 1
- A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Patients With Acquired Immunodeficiency Syndrome (AIDS) Who Are Receiving Zidovudine (AZT) TherapyCompletedNCT00270283Phase 2
- A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) TherapyCompletedNCT00270270Phase 2
- A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their DiseaseCompletedNCT00270010Phase 2
- A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their DiseaseCompletedNCT00269945Phase 2
- A Comparison Study of Kaletra Soft-Gel Capsules and Kaletra Tablets in an African American CohortCompletedNCT00268827Phase 4
- Integrating Buprenorphine Into the SFGH AIDS ProgramCompletedNCT00263458Phase 4
- Metabolic Abnormalities - HIV Infected and Uninfected MalesCompletedNCT00260936
- Motivating HIV+ Women: Risk Reduction and ART AdherenceCompletedNCT00253045Not applicable
- High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV DiseaseStatus unknownNCT00247143Not applicable
- A Study to Assess the Effectiveness of PROCRIT (Epoetin Alfa) Dosing Every 2 Weeks Versus Once a Week in Anemic HIV-infected PatientsTerminatedNCT00246298Phase 2
- Redistribution of Fat and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)CompletedNCT00244803
- Vicriviroc, a CCR5 Inhibitor, Added to an Optimized Antiretroviral Therapy for Previously Treated HIV (VICTOR-E2) (Study P04285WithdrawnNCT00243568Phase 3
- The Intervention With Microfinance for AIDS and Gender Equity (IMAGE) StudyCompletedNCT00242957Not applicable
- The Efficacy of the HIV/AIDS Symptom Management ManualCompletedNCT00241202Not applicable
- Fosamprenavir Expanded AccessCompletedNCT00240552Phase 4
- The CORE Buprenorphine Project - An HIV Primary Care Program DemonstrationCompletedNCT00227357
- Evaluation of Brain Lesions in HIV-infected Patients for Diagnosis of Primary Central Nervous System LymphomaCompletedNCT00226304
- 4-Methylumbelliferone as a Treatment for Chronic HBV/HCVStatus unknownNCT00225537Phase 2
- Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected PatientsTerminatedNCT00221286Phase 3
- Specialized Cognitive-Behavioral Counseling Intervention to Reduce HIV Transmission Risk Behavior in HIV-Infected MenCompletedNCT00218712Not applicable
- Once Daily 3TC, Efavirenz and ddI for HIV InfectionStatus unknownNCT00214435Phase 4
- Efficacy Study of the Vaginal Gel Carraguard to Prevent HIV TransmissionCompletedNCT00213083Phase 3
- Optimizing Antiretroviral Therapy in HIV-Infected Children and AdolescentsTerminatedNCT00207948
- To Assess Compliance With a Once-daily Regimen of Lamivudine, Efavirenz and DidanosineCompletedNCT00207168Phase 4
- The Effects of Anabolic Steroids and Protease Inhibitors on People Living With HIV/AIDSCompletedNCT00202241Not applicable
- Lactate Metabolism Study in HIV Infected PersonsCompletedNCT00202228Phase 4
- Trial of Vitamins Among Children of HIV-infected WomenCompletedNCT00197730Phase 3
- Multivitamin Dosage Regimens in the Prevention of Adverse Pregnancy Outcomes Among HIV-Positive WomenCompletedNCT00197678Phase 3
- The Adult Antiretroviral Treatment and Resistance Study (Tshepo)CompletedNCT00197613Phase 3
- Partnership on Nutrition and HIV/AIDS Research in Tanzania: Exploratory Research Study on Selenium and HIV InfectionCompletedNCT00197561Phase 3
- Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and RibavirinTerminatedNCT00194857Phase 4
- Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide ResistanceCompletedNCT00187551Phase 4
- Evaluate Tolerability of a Recombinant DNA HIV-1 Vaccine in Healthy AdultsCompletedNCT00187148Phase 1
- Evaluation of the Safety of a Polyvalent Virus in Healthy AdultsCompletedNCT00187044Phase 1
- Reducing Risk and Trauma-Related Stress in Persons Living With HIVTerminatedNCT00186030Phase 1/2
- Proton Magnetic Resonance Spectroscopy (1H MRS) in Evaluating the Bone Marrow, Muscle and Adipose Tissue on Normal and Human Immunodeficiency Virus Infected SubjectsStatus unknownNCT00172315
- All About Youth: Evaluation of Sexual Risk Avoidance and Risk Reduction Programs for Middle School StudentsCompletedNCT00167505Not applicable
- Adolescent Impact: A Behavioral Intervention for Adolescents Living With HIV/AIDSCompletedNCT00164385Not applicable
- Monitoring Highly Active Antiretroviral Therapy in HIV-infected Parents in ThailandCompletedNCT00162682Phase 3
- PI Vs. NNRTI Based Therapy for HIV Advanced DiseaseStatus unknownNCT00162643Phase 4
- Prevalence of Proteinuria and Chronic Kidney Disease in Pediatric HIV-Infected PatientsCompletedNCT00153621
- Housing and Health StudyCompletedNCT00153504Not applicable
- Comparison of Facility and Home-based ART Delivery Systems in UgandaCompletedNCT00144365Phase 3
- In-Vivo Response of P. Falciparum to Antimalarial Treatment in HIV-Infected and HIV-Uninfected AdultsCompletedNCT00144352Phase 4
- A Study of Single Dose Nevirapine (NVP) Combined With Combivir® for the Prevention of Mother to Child Transmission (pMTCT) - Treatment Options Preservation Study (TOPS)CompletedNCT00144183Phase 3
- Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIVCompletedNCT00144157Phase 4
- Evaluation of the Preventing AIDS Through Live Movement and Sound (PALMS) Intervention for Minority AdolescentsCompletedNCT00137644Phase 1/2
- A Study of Prevalence of the I50L Mutation When ATV Treated Patients Fail the RegimenCompletedNCT00135447
- A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART RegimenCompletedNCT00135395Phase 3
- Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based RegimenCompletedNCT00135382Phase 3
- Switching HIV-1 Infected Subjects From a Highly Active Anti-Retroviral Treatment (HAART) Regimen Dosed Twice Daily or More Frequently to a Once-Daily RegimenCompletedNCT00135369Phase 3
- A Pilot Study of Atazanavir/Ritonavir/Efavirenz as a Nucleoside Sparing RegimenCompletedNCT00135343Phase 3
- Comparison of HIV Clinic-based Treatment With Buprenorphine Versus Referred Care in Heroin-dependent ParticipantsCompletedNCT00130819Phase 2
- Managed Problem Solving to Increase Treatment Adherence in Individuals With HIVCompletedNCT00130273Not applicable
- 2NN & CHARM Long-Term Follow-up StudyCompletedNCT00127972Phase 4
- AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIVCompletedNCT00126880Phase 2